JMP Securities Healthcare Conference to Be Held in New York

SAN FRANCISCO, Oct 01, 2008 (BUSINESS WIRE) -- JMP Group Inc. (NYSE:JMP), an investment banking and alternative asset management firm, announced today that its broker-dealer subsidiary, JMPSecurities, will host the third annual JMP Securities Healthcare Focus Conference at Le Parker Meridien in New York on Monday and Tuesday, October 6 and 7, 2008.

The two-day conference will feature presentations by senior executives of nearly 90 public and private companies in the biotechnology, medical devices and healthcare services industries before an audience of institutional investors and financial sponsors.

For additional details or to register to attend the event, visit www.jmpsecurities.com/about/events.html or www.twstevent.com/jmp.html.

Companies scheduled to present as of September 30, 2008; subject to change:

A.D.A.M., Inc. ACADIA Pharmaceuticals Inc. Acceleron Pharma, Inc. Achillion Pharmaceuticals, Inc. Alexza Pharmaceuticals, Inc. Allos Therapeutics, Inc. Allscripts Healthcare Solutions, Inc. Alnylam Pharmaceuticals, Inc. American CareSource Holdings, Inc. Anadys Pharmaceuticals, Inc. ARCA biopharma, Inc. Ardea Biosciences, Inc. athenahealth Inc. AtriCure, Inc. AVEO Pharmaceuticals, Inc. AVI BioPharma, Inc. BioCryst Pharmaceuticals, Inc. C. R. Bard, Inc. Cadence Pharmaceuticals, Inc. Celera Corporation Celgene Corporation Celleration, Inc. Cerus Corporation Chem Rx Corporation Concert Pharmaceuticals, Inc. Corcept Therapeutics Incorporated Cypress Bioscience, Inc. Cytokinetics, Incorporated DexCom, Inc. DiagnoCure Inc. Dialysis Corporation of America Echo Therapeutics, Inc. Eclipsys Corp. Enanta Pharmaceuticals, Inc. Endocare Inc. Exelixis, Inc. EyeGate Pharmaceuticals, Inc. Genomic Health, Inc. Given Imaging, Ltd. HeartWare Limited Horizon Therapeutics, Inc. Human Genome Sciences, Inc. HydroCision, Inc. Idenix Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. ImmunoGen, Inc. Incyte Corporation Indevus Pharmaceuticals, Inc. Insulet Corporation Integra LifeSciences Holdings Corporation InterMune, Inc. Inverness Medical Innovations, Inc. Isolagen, Inc. Javelin Pharmaceuticals, Inc. LeMaitre Vascular, Inc. Micrus Endovascular Corporation Monogram Biosciences, Inc. Myriad Genetics, Inc. Neuromed Pharmaceuticals Ltd. Novadaq Technologies Inc. NxStage Medical, Inc. Orexigen Therapeutics, Inc. Osiris Therapeutics, Inc. Perrigo Company Pharmasset, Inc. Pharmaxis Ltd. Pharmerica Corp. Poniard Pharmaceuticals, Inc. Presidio Pharmaceuticals, Inc. PTC Therapeutics Quality Systems Inc. Rigel Pharmaceuticals, Inc. S*BIO Pte Ltd. Sangamo BioSciences, Inc. Somaxon Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc. STARLIMS Technologies Ltd. SXC Health Solutions Corp. Synta Pharmaceuticals Corp. TargeGen, Inc. Transcept Pharmaceuticals, Inc. Vascular Biogenics Ltd. Vertex Pharmaceuticals Incorporated ViroPharma Incorporated Vitae Pharmaceuticals, Inc. XDX, Inc. ZIOPHARM Oncology, Inc.

About JMP Group

JMP Group Inc. is a full-service investment banking and asset management firm that provides investment banking, sales and trading, and equity research services to corporate and institutional clients and alternative asset management products to institutional and high-net-worth investors. JMP Group operates through two subsidiaries, JMP Securities and JMP Asset Management. For more information, visit www.jmpg.com.

SOURCE: JMP Group Inc.

JMP Group Inc. Andrew Palmer, 415-835-8978 [email protected]